Prevention of perinatal HIV transmission: a review of novel strategies (Q35207628)

7 August 2017

1 reference

title

Prevention of perinatal HIV transmission: a review of novel strategies (English)

1 reference

7 August 2017

0 references

prevention of HIV/AIDS

0 references

Athena P Kourtis

1

0 references

Ann C Duerr

series ordinal

2

object named as

Ann Duerr

1 reference

PubMed ID

12943497

7 August 2017

language of work or name

English

0 references

publication date

1 September 2003

1 reference

Expert Opinion on Investigational Drugs

7 August 2017

1 reference

7 August 2017

12

1 reference

7 August 2017

9

1 reference

7 August 2017

1535-1544

1 reference

Perinatal HIV-1 transmission: interaction between zidovudine prophylaxis and mode of delivery in the French Perinatal Cohort

7 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.9.1535

Prevention of mother-to-child HIV transmission in resource-poor countries: translating research into policy and practice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.9.1535

Mother-to-child transmission of the human immunodeficiency virus in Texas

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.9.1535

Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.9.1535

Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.9.1535

Persistent mitochondrial dysfunction and perinatal exposure to antiretroviral nucleoside analogues

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.9.1535

Antiretroviral resistance mutations among pregnant human immunodeficiency virus type 1-infected women and their newborns in the United States: vertical transmission and clades

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.9.1535

After AIDS clinical trial 076: the changing pattern of zidovudine use during pregnancy, and the subsequent reduction in the vertical transmission of human immunodeficiency virus in a cohort of infected women and their infants. Women and Infants Tran

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.9.1535

Efficacy of antenatal zidovudine in reducing perinatal transmission of human immunodeficiency virus type 1. The New York City Perinatal HIV Transmission Collaborative Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.9.1535

Trends in human immunodeficiency virus (HIV) counseling, testing, and antiretroviral treatment of HIV-infected women and perinatal transmission in North Carolina

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.9.1535

Abbreviated regimens of zidovudine prophylaxis and perinatal transmission of the human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.9.1535

Nevirapine: a review of its use in the prevention and treatment of paediatric HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.9.1535

Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.9.1535

A multicenter randomized controlled trial of nevirapine versus a combination of zidovudine and lamivudine to reduce intrapartum and early postpartum mother-to-child transmission of human immunodeficiency virus type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.9.1535

Two-dose intrapartum/newborn nevirapine and standard antiretroviral therapy to reduce perinatal HIV transmission: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.9.1535

Development of resistance mutations in women receiving standard antiretroviral therapy who received intrapartum nevirapine to prevent perinatal human immunodeficiency virus type 1 transmission: a substudy of pediatric AIDS clinical trials group prot

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.9.1535

Comparison of two strategies for administering nevirapine to prevent perinatal HIV transmission in high-prevalence, resource-poor settings

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.9.1535

Efficacy of three short-course regimens of zidovudine and lamivudine in preventing early and late transmission of HIV-1 from mother to child in Tanzania, South Africa, and Uganda (Petra study): a randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.9.1535

Lamivudine-zidovudine combination for prevention of maternal-infant transmission of HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.9.1535

Rapid development of genotypic resistance to lamivudine when combined with zidovudine in pregnancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.9.1535

15 Month follow up of African children following vaginal cleansing with benzalkonium chloride of their HIV infected mothers during late pregnancy and delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.9.1535

Vaginal lavage with chlorhexidine during labour to reduce mother-to-child HIV transmission: clinical trial in Mombasa, Kenya

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.9.1535

Enfuvirtide, an HIV-1 fusion inhibitor, for drug-resistant HIV infection in North and South America

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.9.1535

Prophylactic and therapeutic benefits of short-term 9-[2-(R)-(phosphonomethoxy)propyl]adenine (PMPA) administration to newborn macaques following oral inoculation with simian immunodeficiency virus with reduced susceptibility to PMPA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.9.1535

Phase i/ii trial of the pharmacokinetics, safety, and antiretroviral activity of tenofovir disoproxil fumarate in human immunodeficiency virus-infected adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.9.1535

Tenofovir, adefovir, and zidovudine susceptibilities of primary human immunodeficiency virus type 1 isolates with non-B subtypes or nucleoside resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.9.1535

Method of feeding and transmission of HIV-1 from mothers to children by 15 months of age: prospective cohort study from Durban, South Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.9.1535

Breast-feeding and HIV-1 transmission in resource-limited settings

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.9.1535

Anti-HIV effects of chloroquine: mechanisms of inhibition and spectrum of activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.9.1535

Human immunodeficiency virus load in breast milk, mastitis, and mother-to-child transmission of human immunodeficiency virus type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.9.1535

Immunization with envelope MN rgp120 vaccine in human immunodeficiency virus-infected pregnant women

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.9.1535

Skeptical scientists skewer VaxGen statistics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.9.1535

Lack of association between human immunodeficiency virus type 1 antibody in cervicovaginal lavage fluid and plasma and perinatal transmission, in Thailand

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.9.1535

Efficacy of zidovudine and human immunodeficiency virus (HIV) hyperimmune immunoglobulin for reducing perinatal HIV transmission from HIV-infected women with advanced disease: results of Pediatric AIDS Clinical Trials Group protocol 185.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.9.1535

Phase I/II trial of HIV-1 hyperimmune globulin for the prevention of HIV-1 vertical transmission in Uganda

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.9.1535

Chloroquine accumulates in breast-milk cells: potential impact in the prophylaxis of postnatal mother-to-child transmission of HIV-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.9.1535

HIV-infected pregnant women and vertical transmission in Europe since 1986

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.9.1535

Combination antiretroviral therapy and duration of pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.9.1535

10.1517/13543784.12.9.1535

21 January 2018

Identifiers

DOI

1 reference

7 August 2017

1 reference

PubMed ID

12943497